Lenders extend deadlines for potential resolution under credit agreement
BioXcel Therapeutics lenders have amended their credit agreement to extend March 31 deadlines, now allowing for an acceptable transaction to be completed on or prior to August 28, 2026.
View filing at SEC.gov →